04-07-2025
Strengthening pandemic readiness: South Africa's collaboration with Germany and the EU
This funding will allow CERI to continue surveillance of high-priority pathogens, including respiratory threats such as Avian Influenza H5N1 and emerging coronaviruses.
Image: File
South Africa is reinforcing its leadership role in global pandemic preparedness through a major expansion of its genomic surveillance partnership with Germany and the European Union. The next phase of the Genomic Surveillance Project was officially launched on 24 June at the Centre for Epidemic Response and Innovation (CERI), Stellenbosch University's premier epidemic response institute based at its Tygerberg campus.
The project is a collaboration between CERI and the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), under the broader SAVax Programme. SAVax is co-funded by Germany's Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU), and is implemented in partnership with South Africa's Department of Health and Department of Science, Technology and Innovation.
The new phase brings an additional R9 million in funding, bringing the total investment in the project to R12 million. This funding will allow CERI to continue surveillance of high-priority pathogens, including respiratory threats such as Avian Influenza H5N1 and emerging coronaviruses.
'South Africa is uniquely positioned to play this role,' said Katja Fuehrer, Specialist for Monitoring and Evaluation, Communication, and Commission Management at GIZ. 'The country has a strong industrial base, a highly skilled workforce, and some of the world's leading research institutions. With SAVax, we are tapping into those strengths to bolster Africa's ability to respond to future pandemics more independently and effectively.'
The first phase of the project, which ran from 2023 to 2024, sequenced over 1,000 pathogen genomes, trained more than 50 African scientists, and improved data-sharing protocols to support more effective outbreak responses. The new phase aims to scale these efforts even further by expanding genomic surveillance of respiratory pathogens, strengthening lab capacity in under-resourced provinces, and investing in the training of scientists at historically disadvantaged institutions in South Africa.
Establishing robust systems to monitor and analyse genetic information from pathogens helps South Africa to quickly detect and track changes in viruses proactively. This allows for faster responses to outbreaks and enhances pandemic preparedness in the country and the entire region.
Video Player is loading.
Play Video
Play
Unmute
Current Time
0:00
/
Duration
-:-
Loaded :
0%
Stream Type LIVE
Seek to live, currently behind live
LIVE
Remaining Time
-
0:00
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
Text Color White Black Red Green Blue Yellow Magenta Cyan
Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan
Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan
Transparency Transparent Semi-Transparent Opaque
Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps
Reset
restore all settings to the default values Done
Close Modal Dialog
End of dialog window.
Advertisement
Next
Stay
Close ✕
Ad loading
The launch event at CERI featured a tour of laboratories, a panel discussion, and a grant award ceremony attended by senior officials and diplomats.
'We are delighted to expand the collaboration with South Africa,' said Fulgencio Garrido Ruiz, EU Deputy Ambassador to South Africa. 'There is one aspect at the core of the approach which is research and development. A robust local research framework that enhances self-sufficiency and empowers nations to respond independently to health crisis.'
To date, the Team Europe Initiative MAV+ has mobilised more than 700 million euro's in South Africa, with 10 million euro's allocated to research infrastructure alone.
Sven Hartwig, Deputy Consul General at the German Consulate General in Cape Town, echoed this sentiment. 'It is an honour for the German cooperation to contribute to the Team Europe Initiative MAV+ and to work alongside dedicated partners like CERI,' he said.
'This launch highlights that surveillance for pandemic preparedness relies on partnership and collaboration between the public and private sectors, academia, and civil society. Germany is therefore particularly proud to continue supporting genomic surveillance and remains steadfast in its commitment to share global health goals.'
The launch event at the CERI Headquarters on Stellenbosch University's Tygerberg Campus included a tour of laboratories, a panel discussion and a grant award ceremony attended by senior officials and dignitaries.
Image: Stellenbosch University
Dr Anban Pillay, Deputy Director General from the National Department of Health, emphasised the local value of the initiative. 'The work of CERI and the University of Stellenbosch foster a culture of collaboration.'
Claudia Aguirre, head of the GIZ SAVax programme, underlined the importance of capacity building in this next phase of the partnership. 'In this new collaboration these capacity building efforts will be expanded. We look forward to supporting CERI in its journey to develop science on the African continent and contribute to the development of solutions by African scientists for Africa.'
The broader SAVax programme also aligns with the African Union's ambitious target to locally produce 60% of the continent's vaccines by 2040. By strengthening surveillance, vaccine development, and training programmes, the partnership aims to reduce Africa's dependency on imported vaccines and diagnostics.
'This partnership exemplifies how science, government, and international cooperation can come together to strengthen public health systems and respond more effectively to epidemic threats,' said Professor Tulio de Oliveira, Director of CERI. 'This is especially important for respiratory pathogens and new pathogens like Mpox, which have pandemic potential. The economic cost of a pandemic is so large that preventing it is a very wise and cost-effective investment.'
Fuehrer added that South Africa is now one of only two countries in the Southern Hemisphere conducting real-time genomic tracking of respiratory pathogens, a development that not only strengthens national capacity but fills critical global gaps.
'The data generated in South Africa is shared publicly through international databases, enabling the global health community to monitor pathogens, identify emerging threats, and refine pandemic preparedness,' said Fuehrer. 'It's about shifting the centre of gravity in global health — bringing Africa to the table not just as a recipient, but as a producer, a leader, and a partner.'
